EPISPEC Trademark Information

Trademark by Novartis AG

Pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the cariovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatologoy, in oncology, for use in the gastroenterological area

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: EPISPEC
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
2/25/2011
Serial Number: 78220874
Filing Date: 3/3/2003
Registration Number: 2864968
Registration Date: 7/20/2004
Goods and Services: Pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the cariovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatologoy, in oncology, for use in the gastroenterological area
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 4/27/2004
Last Applicant/Owner:
Novartis AG
Basel
Mark Drawing Code: Typeset (Words/letter/Number)
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Womble Carlyle Sandridge & Rice, PLLC
PO Box 831
Raleigh NC 27602
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
2/25/2011
Correspondent Search:
Maury M. Tepper, III is a correspondent of EPISPEC trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on